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Abstract
Background: Sperm of poor quality can negatively affect embryo development to the blastocyst stage. The aim of
this comparative prospective randomized study was to evaluate the role of an intracytoplasmic morphologically
selected sperm injection (IMSI) in the same infertile couples included in the programme of intracytoplasmic sperm
injection (ICSI) due to their indications of male infertility which had resulted in all arrested embryos following a
prolonged 5-day culture in previous ICSI cycles.
Methods: Couples exhibiting poor semen quality and with all arrested embryos following a prolonged 5-day
culture in previous ICSI cycles were divided into two groups: Group 1: IMSI group (n = 20) with IMSI performed in a
current attempt and Group 2: ICSI group (n = 37) with a conventional ICSI procedure performed in a current
attempt of in vitro fertilization. Fertilization rate, embryo development, implantation, pregnancy and abortion rates
were compared between current IMSI and conventional ICSI procedures, and with previous ICSI attempts.
Results: The IMSI group was characterized by a higher number of blastocysts per cycle than the ICSI group (0.80 vs.
0.65) after a prolonged 5-day embryo culture. There was a significantly lower number of cycles with all arrested
embryos and cycles with no embryo transfer in the IMSI group versus the ICSI group (0% vs. 27.0%, p = 0.048). After
the transfer of embryos at the blastocyst or morula stage (on luteal day 5) a tendency toward higher implantation
and pregnancy rates per cycle was achieved in the IMSI group compared to the ICSI group (17.1% vs. 6.8%; 25.0%
vs. 8.1%, respectively), although not statistically significant. After IMSI, all pregnancies achieved by the blastocyst
transfer were normally on-going, whereas after ICSI, two of three pregnancies ended in spontaneous abortion.
After IMSI, two pregnancies were also achieved by the morula stage embryos, whereas after the conventional ICSI
procedure, embryos at the morula stage did not implant.
Conclusions: The IMSI procedure improved embryo development and the laboratory and clinical outcomes of
sperm microinjection in the same infertile couples with male infertility and poor embryo development over the
previous ICSI attempts.
Background
Infertile patients with abnormal sperm parameters display
an elevated sperm aneuploidy rate, despite a normal blood
cell karyotype [1]. Indications of male infertility, such as
elevated follicle-stimulating hormone (FSH) levels, sperm
concentration of less than 1 million per ml, and severe
teratozoospermia, are significantly associated with higher
numbers of aneuploid sperm [2]. Teratozoospermia can be
associated with aneuploidy [1]. Increased aneuploidy has
been found in both sperm and embryos in couples with
severe male infertility and a history of repeated unsuccess-
ful IVF attempts [3]. Impaired sperm DNA integrity such
as sperm DNA fragmentation or denaturation has been
related to poor semen quality [4] and may negatively affect
embryo development and quality [5]. Overall, a negative
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sperm and embryo development, even before activation of
the embryonic genome, suggesting that sperm can affect
embryogenesis from a very early stage [6].
The motile sperm organelle morphology examination
(MSOME) allows the selection of the best sperm before
oocyte microinjection [7,8]. There have been some reports
on improved implantation and ongoing pregnancy rates
using this sperm selection method, which is used for intra-
cytoplasmic morphologically selected sperm injection
(IMSI) [9]. IMSI enables the selection of motile spermato-
zoa with fine nuclear morphology and without head
vacuoles in real time at high magnification (> 6000 ×),
which are then injected into oocytes. The most predictive
factor of sperm quality is the incidence of vacuoles in the
sperm head. Vacuoles appear to be related to sperm DNA
damage (fragmentation and/or denaturation) [10,11] and
negatively affect human embryo development. The IMSI
method seems to improve the clinical outcome of sperm
microinjection of oocytes in terms of embryo quality and
development, and, consequently, the embryo implantation
and pregnancy outcome [7,8,12-15]. The best spermatozoa
selected by the MSOME are mostly acrosome-reacted
spermatozoa [16]. In spite of the promising publications,
the clinical role of the IMSI method and the indications
for it have not been well established.
The aim of this prospective study was to evaluate the
clinical role of the IMSI procedure in the same couples
displaying indications of male infertility and previously




This prospective study included couples involved in the
ICSI programme at the IVF unit of the University Medi-
cal Centre Ljubljana, from October 2009 to June 2010. A
total of 57 couples, fitting the following inclusion criteria,
were compared in the trial: all couples had indications of
male infertility with poor semen quality and were charac-
terized by all embryos arrested after prolonged 5-day
embryo culture to the blastocyst stage in their previous
conventional ICSI attempts. Poor semen quality was
characterised by the incidence of teratozoospermia by
less than 14% of morphologically normal sperm accord-
ing to the Strict Kruger Criteria, oligozoospermia by a
sperm concentration of less than 20 million per ml and
asthenozoospermia by less than 50% of motile sperm
according the WHO criteria. We excluded patients with
endometriosis and polycystic ovaries and female partners
over 42 years old. After having obtained the patients
informed consent, couples were randomly allocated to
receive the current procedure of sperm microinjection
(IMSI or ICSI) using computer generated random
numbers (unrestricted randomization list), concealed in
sealed, opaque envelopes prepared by a research nurse.
All study participants were blinded as regards their treat-
ment assignment for the duration of the study. The fol-
lowing groups were formed: group 1 was named IMSI
group and included 20 couples who would receive a cur-
rent IMSI procedure, and group 2 was named ICSI group
and included 37 couples who would receive a current
conventional ICSI procedure in the same time period. In
each group of couples, only one current cycle was per-
formed - IMSI or conventional ICSI.
Both groups were compared in terms of laboratory
and clinical outcomes (fertilization, blastocyst, implanta-
tion and pregnancy rates) of the current sperm microin-
jection procedure, IMSI or conventional ICSI. In the
IMSI group, the laboratory and clinical outcomes of the
20 current IMSI cycles were compared with the labora-
tory and clinical outcomes of 33 previously performed
unsuccessful conventional ICSI cycles in these couples
in the same time period. In the ICSI group, the current
ICSI laboratory and clinical outcomes were compared
with the laboratory and clinical outcomes of 46 pre-
viously performed unsuccessful conventional ICSI cycles
in these couples in the same time period.
Ovarian stimulation
Controlled ovarian stimulation was performed using
GnRH agonist buserelin (Suprefact; Hoechst AG, Frank-
furt/Main, Germany) administered from day 22 of the
cycle in a daily dosage of 0.6 ml (600pg) s.c. After 14 days,
the pituitary desensitization was checked by E2 determina-
tion and B-mode ultrasound scan. Once the criteria for
desensitization were fulfilled (E2 ≤ 0.05 nmol/l, follicles ≤
5 mm in diameter and endometrial thickness ≤ 5 mm),
ovarian stimulation with a daily dose of 225 IU highly pur-
ified urinary FSH (Menopur; Ferring, Switzerland) was
started. GnRH agonist administration was continued until
h C Ga d m i n i s t r a t i o n .h C G( P r e g n y l ;N . V .O r g a n o n ,O s s ,
The Netherlands) in a dose of 10,000 IU was administered
when 3 or more follicles reached a diameter of 18 mm.
Ultrasound-guided oocyte retrieval was performed 34-36 h
after hCG administration.
IMSI procedure
Each oocyte was put into a droplet of Sperm Preparation
Medium (Origio, Denmark) under paraffin oil (Origio,
Denmark). The Partner’s semen was prepared by centri-
fugation on a density gradient (100%/40%) of PureSperm
(NidaCon, Sweden) followed by the “swim-up” technique.
The fraction of sperm after the “swim-up” technique was
used to make droplets under paraffin oil.
Up to 2 hours after oocyte retrieval, the morphological
selection of sperm and microinjection of oocytes were
performed. Sperm were selected in dishes with a glass
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The Netherlands) and monitored under an inverted
microscope with a heated stage equipped with differen-
tial interference contrast (DIC) (Nikon ECLIPSE
TE2000-S, Japan). Approximately 5 elongated droplets
of SpermSlow medium (Origio, Denmark) were placed
on a glass dish bottom to immobilize the sperm. A
smaller droplet of prepared sperm was placed near each
SpermSlow droplet. Then the connections were made
between the sperm and the SpermSlow droplets for
sperm to swim into the SpermSlow droplets and to bind
to the hyaluronate (HA). All droplets were covered with
paraffin oil (Origio, Denmark). For observation under
6,000 times magnification, a droplet of immersion oil
was inserted underneath the glass dish (under the
SpermSlow droplet). One droplet of SpermSlow with
bound sperm was monitored by the immersion objec-
tive, differential interference contrast (DIC), and Nikon
Digital Sight DS-Ri1 Camera. The single (mature) sperm
which bound to the HA and had the best morphology
was chosen, aspirated in the microinjection pipette,
scored in three dimensions, and evaluated according to
the morphology and head vacuoles at 6,000 times
magnification.
Sperm selection criteria
The scoring system for the evaluation and selection of the
injected spermatozoa was based on the following classifi-
cation of Cassuto and his co-workers [14]. In each sper-
matozoon, three different parameters were evaluated: head
shape and dimensions in both axes (normal head: an oval
head shape with a regular outline, with a length from 3 to
5 μm, and with a width from 2 to 3 μm according to the
WHO criteria), head vacuoles (number and dimensions)
and head base normality (normal is a U-shape). The head
was scored as follows: 1 point for normality in two or one
axes, and 0 points for abnormalities in both axes. No
vacuoles in the head or a single vacuole with a small dia-
meter was scored with 1 point; otherwise, the score was 0
points. The normal shape of the sperm head basis was
scored with 1 point and abnormal with 0 points. The fol-
lowing formula for the classification of spermatozoon was
used:
Score of spermatozoa = (2 × Head) + (3 × Vacuole) + (Base)
The range for a pre-injected spermatozoon varied
between 0 and 6. Spermatozoa were classified into three
classes according to this formula (Figure 1): Class I:
high-quality spermatozoa with a calculated score of 4 to
6; Class II: medium-quality spermatozoa with a calcu-
lated score of 1 to 3; Class III: low-quality spermatozoa
with a calculated score of 0. In each patient we tried to
select the best sperm for oocyte microinjection. Sperm
of class III were not selected for injection into the
oocytes. The selected spermatozoa of Class I and Class
II were transferred into fresh droplet of Sperm Prepara-
tion Medium covered with paraffin oil in a plastic tissue
culture dish (Nunc 153066), and were microinjected
into the oocytes without the use of polyvinylpyrrolidone
(PVP), as described elsewhere [17].
Conventional ICSI procedure
The sperm selection for microinjection was performed
at a magnification of 200 ×-400 ×. Sperm with severe
head shape defects clearly seen under the magnification
( p i n ,a m o r p h o u s ,t a p e r e d ,r o u n d ,a n dm u l t i n u c l e a t e d
h e a d )w e r ee x c l u d e df r o mm i c r o i n j e c t i o ni n t ot h e
oocyte. No sperm selection based on MSOME was per-
formed for conventional ICSI.
Embryo culturing and grading
After microinjection, the oocytes were washed and trans-
ferred into the Fertilization Medium (Cook, Australia).
The fertilization of the oocytes was checked the next day,
16-18 hours after microinjection. The zygotes were con-
sidered to be normal when they had 2 pronuclei and 2
polar bodies, and abnormal when they did not develop
further (non-cleaved zygotes) or were triploid (with 3
pronuclei). All embryos developed from the normal
zygotes were cultured in the sequential media (Cook,
Australia) to the blastocyst stage. On days 2 and 3, they
were cultured in the Cleavage Medium and on days 4
and 5 in the Blastocyst Medium. On day 5, embryos were
classified according to their developmental stage into
advanced embryos - blastocysts, expressing the inner cell
mass (ICM), trophectoderm (TE), and blastocoel cavity,
and arrested embryos which arrested at the compacted
morula stage or stages with lower numbers of cells (low-
cell embryos). In each blastocyst, the developmental
stage (1-early, 2-developing, 3-developed, 4-expanded, 5-
hatching and 6-hatched), the morphology of the ICM (A-
good: many cells, tightly packed; B-worse: several cells,
loosely grouped; C-bad: very few cells) and the morphol-
ogy of the TE (A-good: many cells, forming a cohesive
layer; B-worse: few cells, forming a loose epithelium;
C-bad: very few large cells) was evaluated based on the
criteria established by Gardner et al. (2000) [18]. Good
blastocyst quality was supposed to be at a developed or
more advanced stage and with good morphology of ICM
and TE, worse blastocyst quality at a developed or more
advanced stage and with good morphology of only one
structure (ICM or TE), and poor blastocyst quality show-
ing abnormal morphology of both structures - ICM
and TE; very poor blastocyst quality was considered to be
at an early stage of development and with abnormal mor-
phology of both structures - ICM and TE (usually com-
bined with the signs of degeneration). At most, 2
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uterus on day 5 by the TDT catheter set (CCD, Neuilly,
France); if blastocysts did not develop, one or two morula
were transfered, whereas lower-cell embryos were not
transfered. Biochemical pregnancy was confirmed by the
positive serum b-hCG test (> 48 mIU/ml) 15 days after
the embryo transfer, and clinical pregnancy by an ultra-
sound scan of the gestational sac and the embryo heart
beats 14 days after the positive b-hCG test.
Statistics
To evaluate the role of sperm selection by their morphol-
ogy, the laboratory and clinical outcomes between the
IMSI and ICSI groups of couples were compared. The
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) statistical program for Microsoft
Windows was used for statistical calculations. The labora-
tory outcomes were expressed as fertilization rate (number
of fertilized oocytes per injected oocytes), number of blas-
tocysts (%), number of blaststocysts per cycle, and number
of cycles with at least one blastocyst (%). The clinical out-
comes were expressed as implantation rate (number of
implanted embryos per transferred embryos), number of
pregnancies, pregnancy rate per cycle, and number of
spontanous abortions. For comparing categorical data, the
chi-square (c
2) test was performed, and Spearman’s rank
correlation coefficient was used as a non-parametric mea-
sure of statistical dependence between the two variables.
Figure 1 Classification of spermatozoa selected at 6,000 × magnification into 3 different categories. Class I - spermatozoa of good
quality, Class II - spermatozoa of worse quality, and Class III - spermatozoa of poor quality. Legend: a,b,c - spermatozoa of Class I; d,e,f -
spermatozoa of Class II; g,h,i - spermatozoa of Class III.
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statistically significant.
Results
During an 8-month period a total of 57 couples were
involved in 20 IMSI cycles (IMSI group)a n d3 7I C S I
cycles (ICSI group). Both groups contained approximately
the same proportion of couples with indications of male
infertility combined with indications of female infertility
(60.0% and 64.8%). The mean female age in the IMSI
group was 35.8 years (min. 27 - max. 40 years) and in the
ICSI group was 32.9 years (min. 25 - max. 42). The mean
sperm concentrations in the IMSI and ICSI groups were
51.3 × 10
6/ml and 50.2 × 10
6/ml, the mean sperm motili-
ties were 53.5% and 49.1%, and the mean sperm
morphologies 10.8% and 10.7% of normal sperm.
In all IMSI cycles it was possible to get at least one
Class I or Class II sperm. Class I sperm were found in 8
(40%) patients; in the other 12 patients only Class II
sperm were possible to find and inject into the oocytes.
In all, 21 of 121 (17%) Class I sperm were found.
For the microinjection of oocytes, the average values
of the IMSI and ICSI group outcome parameters are
shown in Table 1. A total of 356 MII oocytes were
injected by the IMSI (n = 121) and ICSI (n = 235). No
significant differences in the fertilization rates (IMSI:
51.2%; ICSI: 52.7%, p = 1.795) and the proportions of
triploid zygotes (IMSI: 0%; ICSI: 1.2%, p = 0.393) were
observed.
In the IMSI group, a higher number of blastocysts
developed per cycle than in the ICSI group (0.80 vs.
0.65). In the IMSI group, 26.0% of embryos developed to
the blastocyst stage after the IMSI procedure, whereas
in the previous ICSI cycles all embryos were arrested at
the lower developmental stages. In the ICSI group,
19.3% of embryos developed to the blastocyst stage,
whereas in the previous ICSI cycles all embryos were
developmentally arrested. There was a tendency toward
a higher number of cycles with at least one blastocyst in
the current IMSI group than current ICSI group (50%
and 35.1%, p = 0.750, respectively); although, it was not
statistically significant (Table 1).
When blastocysts developed, they did not differ in their
quality according the procedure of sperm microinjection,
IMSI or ICSI. There were approximately the same pro-
portions of early (25.0% and 29.2%), developing (18.7%
and 8.3%), developed (18.7% and 29.2%) and expanded
(37.5% and 33.3%) blastocysts in current IMSI and ICSI
group cycles. Hatching or hatched blastocysts were not
observed regardless of the group of couples. In both IMSI
and ICSI groups there were also approximately the same
proportions of blastocysts with good (33.3% and 35.3%),
worse (33.3% and 41.2%), poor (25% and 17.6%), and very
poor (8.3% and 5.9%) morphology of the ICM or TE.
In IMSI group, 18 IMSI-derived blastocysts were trans-
ferred in 10 (50%) cycles (1.8/cycle) and 3 pregnancies
were achieved (Table 2). The clinical pregnancy rate per
blastocyst transfer was 30%. In the rest of the 10 IMSI
Table 1 Results of the IMSI vs. ICSI procedure in couples with poor embryo development - all embryos arrested
following a prolonged 5-day culture in previous cycles of ICSI
Method of in vitro fertilization









No. of couples 20 20 37 37
Average female age (years) 34.7 ± 4.02 35.8 ± 4.36 32.0 ± 4.04 32.9 ± 4.48
No. of injected oocytes (%) 158 (74.9%) 121 (75.1%) 227 (80.2%) 235 (79.3%)
No. of fertilized oocytes (zygotes) (%) 86 (54.4%) 62 (51.2%) 129 (56.8%) 124 (52.7%)
No. of triploid zygotes (%) 3 (1.9%) 0 (0%) 3 (1.1%) 3 (1.2%)
Average no. of embryos per cycle 2.6 ± 6.21 3.1 ± 3.45 2.8 ± 6.94 3.3 ± 3.29
No. of blastocysts (%) 0 (0%) 16 (26.0%) 0 (0%) 24 (19.3%)
No. of blastocysts pr cycle 0 0.80 0 0.65
No. of arrested embryos - morula (%) 26 (30.2%) 17 (27.4%) 41 (31.7%) 25 (19.1%)
No. of embryos arrested prior to the morula stage (%) 44 (51.2%) 29 (47.0%) 88 (68.2%) 75 (60.5%)
No. of cycles with at least one blastocyst (%) 0 (0%) 10 (50.0%) 0 (0%) 13 (35.1%)
No. of cycles with all embryos arrested (%) 33 (100%) 0 (0%)
a 46 (100%) 10 (27.0%)
b
Implantation rate 0% 17.1% (6/35) 0% 6.8% (3/44)
No. of pregnancies 0 5 0 3
Pregnancy rate per cycle 0% 25.0% 0 8.1%
Values are average ± SD.
a vs. b statistically significant difference as evaluated by the chi-square test (p < 0.05).
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into the uterus. Two pregnancies were achieved thus
giving a 20% pregnancy rate per morula transfer.
In the ICSI group, 24 ICSI-derived blastocysts were
transferred in 13 (35.1%) cycles (1.8/cycle) and 3 preg-
nancies were achieved. The clinical pregnancy rate per
blastocyst transfer was 23% and tended to be lower than
in the IMSI group (23% vs. 30%, p = 0.180), although
not statistically significant. All pregnancies achieved by
the blastocyst transfer were singleton and two pregnan-
cies terminated with a spontaneous abortion. In 14 ICSI
cycles, at least one morula was transferred into the
uterus but no pregnancies were achieved (Table 2).
There was a significantly lower proportion of cycles
with all embryos arrested and a consequently lower pro-
portion of cycles with no embryo transfer in the current
IMSI group compared to the current ICSI group (0% vs.
27.0%; p = 0.048; 0%), as shown in Table 2.
The overall implantation and pregnancy rates (follow-
ing blastocyst and morula transfers) in the current IMSI
cycles of the IMSI group tended to be higher than in the
current ICSI cycles of the ICSI group (17.1% vs. 6.8%,
p = 1.162; 25.0% vs. 8.1%; p = 1.829, respectively), as
shown in Table 1 although not statistically significant.
In terms of pregnancy, all pregnancies achieved by the
blastocyst transfer in the IMSI group were singleton and
normally on-going, whereas two from these pregnancies
achieved by the blastocyst transfer in the ICSI group ter-
minated with a spontaneous abortion. After IMSI-derived
morula transfer, one pregnancy terminated with a spon-
taneous abortion and another was a normally on-going
singleton pregnancy.
Discussion
T h er e s u l t so ft h i ss t u d yh a v es h o w nt h a tt h eI M S Ip r o -
cedure is a method of choice in infertile couples with
indications of male infertility and with poor embryo
development in previous ICSI attempts. Couples with all
embryos arrested after a prolonged embryo culture of 5
days are relatively rare and represent the most difficult
cases in the in vitro fertilization programme; therefore,
the studied groups in our study are relatively small. The
benefits of IMSI to improve outcomes of male infertility
patients have already been published [7,8,13,14]. How-
ever, the data about the improvement in laboratory and
clinical outcomes when comparing ICSI and IMSI in the
same couples is new.
Similar to our study, Vanderzwalmen et al. (2008)
observed in a sibling oocyte study including 20 infertile
couples that sperm selection at high magnification before
ICSI, according to the morphology and head vacuoles,
improves embryo development to the blastocyst stage.
They divided sperm into 4 categories and concluded that
optimal sperm without vacuoles or with 1 or 2 small
vacuoles in their heads produced significantly higher
rates of blastocysts (56.3 and 61.4%, respectively) than
sperm with large head vacuoles or large head vacuoles
combined with other morphological abnormalities (5.1
Table 2 Clinical outcome of IMSI and ICSI procedures according to the developmental stage of the transferred
embryos in comparison with previous ICSI cycles
Method of in vitro fertilization








No. of transfers 0 10 0 13
No. of transferred embryos 0 18 0 24
Average no. of transferred embryos per transfer 0 1.8 ± 0.29 0 1.8 ± 0.70
No. of pregnancies 0 3 0 3
Pregnancy rate per transfer 0% 30% 0% 23.0%
Spontaneous abortions 0 0 0 2
Morula transfers
No. of transfers 21 10 35 14
No. of transferred embryos 26 17 41 20
Average no. of transferred embryos per transfer 1.2 ± 0.82 1.7 ± 0.34 1.2 ± 0.75 1.4 ± 0.7
No. of pregnancies 0 2 0 0
Pregnancy rate per transfer 0% 20% 0% 0%
Spontaneous abortions 0 1 0 0
Cycles with no embryo transfer due to developmental arrest
No. of cycles 12 (36.0%) 0 (0%)
a 11(24.0%) 10 (27.0%)
b
Values are average ± SD
a vs. b statistically significant difference as evaluated by the chi-square test (p < 0.05)
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that the IMSI procedure improved fertilization and blas-
tocyst rates in 27 infertile couples [14].
In patients included in this study, the mean sperm
counts (51.3 and 50.2 × 10
6/ml respectively) were reason-
able and the mean morphologies (10.8% and 10.7%
respectively) were within the original Kruger classifica-
tion of “subfertile/fertile” with good prognosis. It is
known that normal classical parameters of sperm quality
are not always related to fertility and good prognosis,
because sperm might have some other functional
abnormalities, i.e. sperm DNA fragmentation and head
vacuoles. Therefore the IMSI procedure possibly
improved the laboratory and clinical outcome of sperm
m i c r o i n j e c t i o ni nt h i sg r o u p . Twenty-four blastocysts
were also transferred in the regular ICSI group in the
current study. This might also reflect the fact that sperm
quality was possibly improved; it is known that the sperm
quality is not a constant but may vary. It should also be
stressed that in a relatively high proportion of couples of
both groups, indications of male infertility were com-
bined with indications of female infertility, and therefore
the female effect on the laboratory and clinical outcome
of sperm microinjection could not be completely
excluded.
It seems that the positive effect of sperm selection at
high magnification is expressed at later stages of embryo
development to the blastocyst stage. In the present study
there was no significant positive effect of the IMSI proce-
dure on the fertilization of the oocytes and abnormal tri-
ploid fertilization. Mauri et al. (2010) found that IMSI did
not improve the quality of day 2 embryos in comparison
with ICSI [19] in a sibling oocyte study. Similarly, Van-
derzwalmen et al. found that IMSI provided no significant
difference in embryo quality up to day 3 but led to a better
development of embryos to the blastocyst stage when
compared to conventional ICSI [13]. IMSI seems to posi-
tively affect embryo development after the activation of
the embryonic genome and represents a late paternal posi-
tive effect, which is associated with an increased incidence
of sperm DNA fragmentation [20]. IMSI improves the
embryo development to the blastocyst stage via the selec-
tion of sperm without vacuoles in their heads, which is
influenced by the incidence of sperm DNA fragmentation
[10,11].
Our results showed improved embryo development
and quality after the IMSI procedure reflected in a higher
number of blastocysts per cycle and a significantly lower
proportion of cycles with no embryo transfer due to
developmental arrest in comparison with the conven-
tional ICSI procedure. There was also a tendency toward
a higher blastocyst rate per cycle, a lower proportion of
arrested embryos (i.e. less than the morula stage by day 5
of the culture), and a lower proportion of cycles with all
embryos arrested after a prolonged 5-day culture in com-
parison with ICSI procedure. In current IMSI cycles,t h e
implantation and pregnancy rates tended to be better
than in current ICSI cycles, in spite of a tendency to a
higher mean female age. IMSI seems to be promising for
older women but needs to be confirmed in research with
a larger number of couples.
Embryo culture, especially prolonged embryo culture to
the blastocyst stage (5 days), can serve as a strong diag-
nostic tool [21] reflecting indications of male and female
infertility and yielding useful information regarding the
implantation potential of the human embryo. In this
study, there was no significant difference in the preg-
nancy rates after the IMSI and ICSI procedures after
blastocyst transfer, but after ICSI two out of three preg-
nancies terminated by spontaneous abortion, whereas
after IMSI there were no spontaneous abortions. This
shows that the IMSI procedure might provide more
“healthy” blastocysts without chromosomal abnormal-
ities, possibly, in spite of very comparable development
and morphology to ICSI-derived blastocysts. From the
literature it is known that embryos with normal morphol-
ogy may also be chromosomally abnormal and can
develop to the blastocyst stage [22]. This was also true
for the morula transfer, when there was no blastocyst on
day 5. It is interesting that morula also implanted suc-
cessfully after the IMSI procedure, whereas ICSI-derived
morula did not implant.
The results of this research showed that by IMSI it is
possible to improve the laboratory and clinical outcome
of in vitro fertilization in couples with previous poor
embryo development.
Conclusions
We can conclude that sperm selection at high magnifica-
tion using differential interference contrast (DIC),
immersion objective, and a digital camera is useful in
identifying more precisely the sperm morphology and the
size and the number of sperm head vacuoles that exert a
considerable negative effect on embryo development to
the blastocyst stage, and consequently on the pregnancy.
By using the IMSI procedure the embryo development
and pregnancy might be improved in couples with indi-
cations of male infertility, poor sperm quality and poor
embryo development, i.e. on all embryos arrested follow-
ing a prolonged 5-day culture in previous conventional
ICSI attempts.
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